吉林激光治疗包皮包茎(吉林做包皮手术需花多少钱) (今日更新中)

The brother of the accused Parkland shooter has been involuntarily committed to a mental facility, sources tell Scripps station WPTV in West Palm Beach, Florida.Nikolas Cruz’s brother was involuntarily committed to a mental institution, under Florida's Baker Act.The Palm Beach County Sheriff’s Office detained Cruz Friday afternoon, according to sources. The Broward Sheriff’s Office placed the Baker Act on Cruz. Under Florida's Baker Act, an adult can be held for an involuntary exam for up to 72 hours under the law. Anyone 17 or younger can be help for up to 12 hours.This is a developing story. More information will be posted once available.  692

The Food and Drug Administration released updated safety standards Tuesday for makers of COVID-19 vaccines despite efforts by the White House to block them, clearing the way for requirements that are widely expected to prevent the introduction of a vaccine before Election Day.In the new guidelines posted on its website, the FDA said vaccine makers should follow trial participants for at least two months to rule out any major side effects before seeking emergency approval. That standard had been a sticking point between the FDA and White House officials, who said it could unreasonably delay the availability of COVID-19 vaccines.President Donald Trump has repeatedly insisted a vaccine could be authorized before Nov. 3, even though top government scientists working on the effort have said that timeline is very unlikely. On Monday Trump said vaccines are coming “momentarily,” in a video recorded after he returned to the White House.Former FDA officials have warned that public perception that a vaccine was being rushed out for political reasons could derail efforts to vaccinate millions of Americans.A senior administration official confirmed Monday that the White House had blocked FDA’s plans to formally publish the safety guidelines based on the two-month data requirement, arguing there was “no clinical or medical reason” for it.But on Tuesday, the FDA posted the guidance on its website, making clear that regulators plan to impose the safety standards for any vaccine seeking an expedited path to market.FDA Commissioner Stephen Hahn said in a statement that he hoped the guidelines would help “the public understand our science-based decision-making process that assures vaccine quality, safety and efficacy.”The requirements are aimed at companies seeking rapid approval through the FDA’s emergency authorization pathway. That accelerated process, reserved for health emergencies, allows medical products onto the market based on a lower bar than traditional FDA approval. But FDA has made clear only vaccines that are shown to be safe and effective will be authorized for coronavirus.Former FDA acting commissioner Dr. Stephen Ostroff said the requirements seem reasonable given the agency is in largely “uncharted territory” in terms of considering emergency use of a vaccine. The agency has only previously cleared one vaccine through the method — a decades-old shot that was authorized to prevent anthrax poisoning in 2005.“There really is no margin for error here,” Ostroff said. “Even when you’re talking about limited use of a vaccine there has to be some level of assurance that there isn’t a risk here that would far outweigh the benefit.”Dr. Peter Marks, the head of FDA’s vaccine division, said Tuesday that the two-month follow-up requirement was chosen to be “something reasonably aggressive, but not too conservative — right in the middle.” He spoke at a symposium organized by Johns Hopkins University.Initial doses of vaccines for emergency use would likely be reserved for medical workers and people with health conditions that make them particularly vulnerable to coronavirus. Full FDA approval for the general population will require significantly more data and is not expected until mid-2021.The White House attempt to block the guidance followed a string of instances in which the Trump administration has undercut its own medical experts working to combat the pandemic. FDA’s Hahn has been attempting to shore up public confidence in the vaccine review process for weeks, vowing that career scientists, not politicians, will decide if the shots are safe and effective.Pfizer CEO Albert Bourla has stoked excitement by saying that he expects data on whether the company’s candidate works to be ready in late October. But a number of variables would still have to align for the company to submit, and the FDA to review and greenlight, a vaccine application before Nov. 3. Pfizer’s competitors Moderna, AstraZeneca and Johnson & Johnson are working on longer research timelines.Vaccine development typically takes years, but the U.S. government has invested billions in efforts to accelerate the process and help multiple drugmakers prepare multiple candidates. All the doses will be purchased by the federal government for use vaccinating the U.S. population.Beyond exposing the rift between the White House and FDA, the delay in releasing the guidelines may have had limited practical effect.FDA scientists have been discussing the guidelines publicly for weeks and have made clear that the recommendations have already been shared with each of the vaccine developers.Former FDA Commissioner Scott Gottlieb said Tuesday that drugmakers depend on the FDA’s science-based endorsement to vouch for the safety and effectiveness of their products.“I can’t imagine a circumstance where a sponsor would challenge or seek to undermine the FDA’s role here,” Gottlieb said at the COVID-19 symposium. “This is precisely the moment when we need an objective, neutral arbiter.”Last week, Gottlieb and six other former FDA commissioners blasted the Trump administration for “undermining the credibility” of the agency in a op-ed calling for the release of the then-stalled vaccine guidelines.“Scientists should make decisions based on data, unfettered by political pressure or the intrusions of ideology or vested interests,” the officials wrote.___AP Medical Writer Lauran Neergaard contributed to this report.___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 5644

The dead gunman in the Sutherland Springs, Texas, church shooting was a former airman who was discharged from the military for bad conduct and may have been conducting target practice on his property last week, sources say.Details continue to trickle out Monday about the man police say is responsible for the worst mass shooting in Texas history.Devin Patrick Kelley, 26, was killed after the shooting, either by his own hand or by a gunshot from a local resident who engaged and chased Kelley, police say. 515

The FBI raided Michael Cohen's office on Monday, the personal lawyer to President Donald Trump who allegedly oversaw a 0,000 payment to adult film actress Stormy Daniels in the days leading up to the 2016 election, the New York Times reported. According to the Times, Special Counsel Robert Mueller issued a referral for the raid, although the search does not appear to be directly related to his ongoing investigation of Russian meddling and possible coordination with the Trump campaign during the 2016 election. The Times report does indicate, however, that the raid stemmed from information Mueller uncovered and gave to prosecutors.In order to secure a raid, Mueller went to US Attorney Geoffrey Berman, who was appointed in January. Berman took the information to a federal judge, who green lighted the raid. Berman replaced acting US Attorney Joon Kim, who replaced Preet Bharara. Bharara was fired by Trump after he refused to resign when Trump demanded that all US Attorneys who worked under President Barack Obama to step down. Despite Berman being a Trump appointee, the President said the investigation is a "witch hunt.""I have this witch hunt constantly going on, it is a real disgrace," Trump said. "It is an attack on what we all stand for," It is at an all new level of unfairness."Attorney General Jeff Sessions vowed to stay out of the Mueller investigation shortly after being confirmed as AG. He assigned his Deputy Attorney General Rod Rosenstein to oversee Mueller's investigation. Trump admitted on Monday that had he known that Sessions would recuse himself, that he would have looked for a different attorney general."The attorney general made a terrible mistake when he did this and when recused himself or he certainly should have let us know if he was going to recuse himself and we would have put a different attorney general in," Trump said. "So he made what I consider to be a very terrible mistake for the country. But you'll figure that out."Trump was asked whether he should fire Mueller. "I think it's a disgrace what's going on. We'll see what happens..Many people have said you should fire him," Trump said. "Again, they found nothing and in finding nothing that's a big statement because you know the person who is in charge of the investigation."Cohen was reportedly responsible for paying Daniels 0,000 to keep quiet about a previous sexual encounter with Trump. Daniels has since gone public about the alleged sexual encounter, recently appearing on "60 Minutes" in an interview with Anderson Cooper. The possible payment, which Trump has claimed he has no knowledge of, has also brought questions on its legality, and whether the payment by Cohen constituted as an undisclosed campaign contribution. Cohen's lawyer on Monday told the New York Times the raid was “completely inappropriate and unnecessary.” 2927

The first large head-to-head comparison of two opioid addiction medications found that, although they were equally effective in getting people off of high levels of opioids, users had a significantly more difficult time starting a regimen of naltrexone, compared with buprenorphine.Buprenorphine is commonly known by the the brand name Suboxone, and naltrexone is sold under the brand name Vivitrol.The study, published Tuesday in the Lancet, looked at 570 patients with opioid addiction at eight inpatient treatment centers across the country for 24 weeks. Half of the group was assigned to naltrexone and the other half to bupenorphine.Six percent of those enlisted to use buprenorphine were unable to start their treatment, whereas 28% of those assigned to naltrexone dropped out before starting the therapy. 824

来源：资阳报